Valuation: Astellas Pharma Inc.

Market Cap 4,23700Cr 2.66TCr 2.31TCr 2.16TCr 1.97TCr 3.71TCr 2,53700Cr 3.77TCr 25TCr 9.91TCr 1,27000Cr 9.99TCr 9.77TCr P/E 2027 *
11.8x
P/E 2028 * 12.4x
Enterprise Value 4,24800Cr 2.67TCr 2.31TCr 2.16TCr 1.97TCr 3.72TCr 2,54400Cr 3.78TCr 25TCr 9.94TCr 1,27300Cr 10TCr 9.8TCr EV / Sales 2027 *
1.86x
EV / Sales 2028 * 1.82x
Free-Float
98.88%
Yield 2027 *
3.4%
Yield 2028 * 3.51%
1 day+1.55%
1 week+8.59%
Current month+7.31%
1 month+10.32%
3 months+2.74%
6 months-6.66%
Current year+12.90%
1 week 2,135.5
Extreme 2135.5
2,377
1 month 2,109
Extreme 2109
2,377
Current year 2,041
Extreme 2041
2,717
1 year 1,557.5
Extreme 1557.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 10/02/2023
Director of Finance/CFO 54 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 63 01/06/2019
Director/Board Member 58 01/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%+8.59%+46.27%+5.14% 2.67TCr
-0.73%+9.62%+92.54%+131.51% 1,09800Cr
-0.57%+1.91%+49.46%+49.44% 63TCr
+0.89%+2.48%+25.78%+64.17% 44TCr
-1.13%+3.13%+49.78%+39.13% 37TCr
-0.74%+1.01%+31.08%+38.64% 30TCr
-1.22%+0.89%+7.32%+7.38% 25TCr
-0.78%+6.25%+45.36%+57.86% 23TCr
+0.34%-0.13%-4.77%-50.50% 21TCr
+2.45%+0.78%+13.14%+70.38% 16TCr
Average +0.07%+1,717.61%+35.59%+41.32% 37.11TCr
Weighted average by Cap. -0.31%+1,338.18%+50.17%+66.22%

Financials

2027 *2028 *
Net sales 2,28800Cr 1.44TCr 1.25TCr 1.17TCr 1.06TCr 2TCr 1,37000Cr 2.04TCr 14TCr 5.36TCr 69TCr 5.39TCr 5.28TCr 2,10100Cr 1.32TCr 1.14TCr 1.07TCr 976.5Cr 1.84TCr 1,25800Cr 1.87TCr 13TCr 4.92TCr 63TCr 4.95TCr 4.85TCr
Net income 34TCr 215.61Cr 186.85Cr 174.92Cr 159.6Cr 300.34Cr 21TCr 305.39Cr 2.05TCr 803.6Cr 10TCr 809.55Cr 791.91Cr 32TCr 203.45Cr 176.31Cr 165.05Cr 150.6Cr 283.4Cr 19TCr 288.16Cr 1.94TCr 758.26Cr 9.71TCr 763.88Cr 747.24Cr
Net Debt 1.11TCr 6.98Cr 6.05Cr 5.67Cr 5.17Cr 9.73Cr 666.12Cr 9.89Cr 66Cr 26Cr 333.41Cr 26Cr 26Cr -42TCr -262.28Cr -227.29Cr -212.78Cr -194.15Cr -365.35Cr -25TCr -371.49Cr -2.49TCr -977.54Cr -13TCr -984.77Cr -963.32Cr
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
10/26/10 JP¥2,363.00 +1.55% 62,87,500
07/26/07 JP¥2,327.00 +1.68% 80,01,800
06/26/06 JP¥2,288.50 +6.00% 1,03,52,900
05/26/05 JP¥2,159.00 -0.44% 53,88,800
04/26/04 JP¥2,168.50 -0.34% 67,19,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,363.00JPY
Average target price
2,413.08JPY
Spread / Average Target
+2.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock